Kronox Lab Sciences IPO

Kronox Lab Sciences IPO is a book built issue of Rs 130.15 crores. The issue is entirely an offer for sale of 0.96 crore shares.

Kronox Lab Sciences IPO opens for subscription on June 3, 2024 and closes on June 5, 2024. The allotment for the Kronox Lab Sciences IPO is expected to be finalized on Thursday, June 6, 2024. Kronox Lab Sciences IPO will list on BSE, NSE with tentative listing date fixed as Monday, June 10, 2024.

Kronox Lab Sciences IPO price band is set at ₹129 to ₹136 per share. The minimum lot size for an application is 110 Shares. The minimum amount of investment required by retail investors is ₹14,960. The minimum lot size investment for sNII is 14 lots (1,540 shares), amounting to ₹209,440, and for bNII, it is 67 lots (7,370 shares), amounting to ₹1,002,320.

Pantomath Capital Advisors Pvt Ltd is the book running lead manager of the Kronox Lab Sciences IPO, while Kfin Technologies Limited is the registrar for the issue.

 

Kronox Lab Sciences IPO Details

IPO DateJune 3, 2024 to June 5, 2024
Listing DateJune 10, 2024
Face Value₹10 per share
Price Band₹129 to ₹136 per share
Lot Size110 Shares
Total Issue Size9,570,000 shares
(aggregating up to ₹130.15 Cr)
Offer for Sale9,570,000 shares of ₹10
(aggregating up to ₹130.15 Cr)
Issue TypeBook Built Issue IPO
Listing AtBSE, NSE
Share holding pre issue37,104,000
Share holding post issue37,104,000

Kronox Lab Sciences IPO Reservation

Investor CategoryShares Offered
QIB Shares OfferedNot more than 50% of the Net Issue
Retail Shares OfferedNot less than 35% of the Net Issue
NII (HNI) Shares OfferedNot less than 15% of the Net Issue

Kronox Lab Sciences IPO Timeline (Tentative Schedule)

Kronox Lab Sciences IPO opens on June 3, 2024, and closes on June 5, 2024.

IPO Open DateMonday, June 3, 2024
IPO Close DateWednesday, June 5, 2024
Basis of AllotmentThursday, June 6, 2024
Initiation of RefundsFriday, June 7, 2024
Credit of Shares to DematFriday, June 7, 2024
Listing DateMonday, June 10, 2024
Cut-off time for UPI mandate confirmation5 PM on June 5, 2024

Kronox Lab Sciences IPO Lot Size

Investors can bid for a minimum of 110 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (Min)1110₹14,960
Retail (Max)131430₹194,480
S-HNI (Min)141,540₹209,440
S-HNI (Max)667,260₹987,360
B-HNI (Min)677,370₹1,002,320
 

About Kronox Lab Sciences Limited

Incorporated in 2008, Kronox Lab Sciences Limited is a manufacturer of high-purity speciality fine chemicals for diverse end-user industries. The company’s High Purity Specialty Fine Chemicals are used in various applications such as manufacturing APIs, pharmaceutical formulations, scientific research, nutraceuticals, biotech applications, agrochemical formulations, personal care products, metal refineries, and animal health products.

The company offers a wide range of over 185 products, including phosphate, sulphate, acetate, chloride, citrate, nitrates, nitrites, carbonate, EDTA derivatives, hydroxide, succinate, gluconate, and others. These products are supplied to customers in India and more than 20 countries worldwide.

The company exports its products to countries such as United States, Argentina, Mexico, Australia, Egypt, Spain, Turkey, United Kingdom, Belgium, United Arab Emirates, China, among others.

Kronox Lab Sciences Limited Financial Information 

Kronox Lab Sciences Limited’s revenue increased by 16.99% and profit after tax (PAT) rose by 21.94% between the financial year ending with March 31, 2023 and March 31, 2022.

Period Ended31 Dec 202331 Mar 202331 Mar 202231 Mar 2021
Assets66.9654.0356.7937.65
Revenue68.4497.5083.3463.24
Profit After Tax15.4716.6213.639.73
Net Worth60.2844.6840.3526.81
Reserves and Surplus15.567.5840.1126.57
Total Borrowing  0.640.01
Amount in ₹ Crore

Key Performance Indicator

The market capitalization of Kronox Lab Sciences IPO is Rs 504.61 Cr.  

KPI as of December 31, 2023.

KPIValues
ROE25.66%
ROCE33.15%
RoNW25.66%
P/BV8.37
PAT Margin (%)

22.6

Scroll to Top